Rest-Of-Europe Veterinary PoC Diagnostics Market Size, Share,Trends, Growth Analysis Report, 2031

Name: Rest-Of-Europe Veterinary PoC Diagnostics Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Rest Of Europe Veterinary PoC Diagnostics Market analysis

Part of: Veterinary PoC Diagnostics Market (Global)

The Rest Of Europe Veterinary PoC Diagnostics Market was valued at $34.6 Million in 2026 and projected to reach to $46.6 Million by 2031, representing a compound annual growth rate of 6.1%. The Rest Of Europe veterinary PoC diagnostics market is positioned for steady expansion through 2031, driven by increasing pet ownership rates and growing consumer spending on animal healthcare.

Rest Of Europe Veterinary PoC Diagnostics Market (2026-2031) : Size and Share

CAGR of

USD Million

Rest Of Europe Veterinary PoC Diagnostics Market Trends and Insights

Rest Of Europe represents a significant secondary market within the broader European veterinary diagnostics landscape, driven by increasing pet ownership, rising awareness of animal health, and growing adoption of rapid diagnostic solutions in veterinary clinics and animal hospitals.
The region's market growth reflects broader European trends toward preventive care and early disease detection in companion and livestock animals. Rest Of Europe's 6.1% compound annual growth rate (CAGR) through 2031 indicates moderate but consistent market expansion, supported by improving veterinary infrastructure and regulatory frameworks across smaller European economies.
Rest Of Europe is benefiting from technology transfer from Western European markets and increasing investment in animal healthcare services.
The market dynamics in Rest Of Europe are shaped by cost-consciousness among veterinary practitioners, demand for portable diagnostic devices, and the need for rapid turnaround times in clinical decision-making..

Key Market Statistics

CAGR (2026-2031) 6.1% CAGR
Market Size, 2026 ~USD 34.6 Million
Forecast, 2031 ~USD 46.6 Million
Country Rest Of Europe

Rest Of Europe Veterinary PoC Diagnostics Market Overview

Market Valuation Growth :

Rest Of Europe veterinary PoC diagnostics market valued at USD 34.6 million in 2026, expanding to USD 46.6 million by 2031, representing a robust 6.1% CAGR over the forecast period.

Pet Ownership Expansion :

Rising pet ownership across Eastern and Southern European countries is driving demand for accessible diagnostic solutions, supporting market growth in secondary European markets.

Regional Market Position :

Rest Of Europe represents a significant secondary market within the broader European veterinary diagnostics landscape, with distinct growth dynamics separate from Western European markets.

Healthcare Awareness Surge :

Increasing awareness of animal health and preventive care among Rest Of Europe consumers is accelerating adoption of point-of-care diagnostic technologies in veterinary practices.

Rest Of Europe Veterinary PoC Diagnostics Market Dynamics

Emerging economies within the region are adopting modern diagnostic technologies at accelerating rates, supported by improving veterinary infrastructure and rising awareness of preventive care.
The 6.1% CAGR reflects moderate but consistent growth as regional markets mature and accessibility to diagnostic solutions improves across diverse geographic areas. Key growth catalysts include expanding middle-class populations with disposable income for pet care, regulatory harmonization efforts, and increasing availability of affordable PoC diagnostic devices.
Regional veterinary practices are increasingly investing in point-of-care solutions to enhance service offerings and operational efficiency.
Market consolidation and localized product development strategies by major players will further support market penetration in Rest Of Europe's diverse veterinary landscape..

Related Ecosystem

Key Takeaways

Rest Of Europe's veterinary PoC diagnostics market will grow from USD 34.6 million (2026) to USD 46.6 million (2031) at a 6.1% CAGR.
Rest Of Europe is experiencing increased adoption of rapid diagnostic solutions driven by rising pet ownership and preventive care awareness.
Rest Of Europe's market growth is supported by improving veterinary infrastructure and regulatory harmonization across smaller European economies.
Rest Of Europe demonstrates cost-sensitive demand for portable, efficient diagnostic devices in veterinary clinical settings.

Veterinary PoC Diagnostics Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	MOLECULAR DIAGNOSTICS (Technology)
Forecast Period	2026�2031
Growth Rate	CAGR of 7.7% from 2026 to 2031
Largest Segment	CONSUMABLES (Product)
Market Size Base Year (Billions)	~USD 1.19 (2026)
Revenue Forecast (Billions)	~USD 1.72 (2031)
Segments Covered	Product, Animal Type, Type, Technology, Livestock Type, Molecular Diagnostics

Rest Of Europe Veterinary PoC Diagnostics Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product

Consumables
Instruments

By Animal Type

Companion Animals
Livestock

By Type

Cat
Cattle
Crispr-Based
Dog
Horse
Isothermal Amplification
Other Companion Animals
Other Livestock
Pcr-Based
Pig
Poultry

By Technology

Immunodiagnostics
Molecular Diagnostics
Other Technologies

By Livestock Type

Cattle
Other Livestock
Pig
Poultry

By Molecular Diagnostics

Crispr-Based
Isothermal Amplification
Pcr-Based

Target Audience

Veterinary Diagnostics Manufacturers : Manufacturers need Rest Of Europe-specific market data to develop localized product strategies, identify distribution partnerships, and prioritize regional expansion investments.
In Vitro Diagnostics Companies : IVD companies require detailed regional insights to assess market potential, competitive positioning, and regulatory requirements for veterinary PoC solutions in Rest Of Europe.
Veterinary Practice Operators : Practice owners and operators need market intelligence to benchmark diagnostic capabilities, evaluate technology investments, and understand regional adoption trends.
Healthcare Investment Firms : Investment professionals require accurate market forecasts and regional growth drivers to evaluate acquisition targets and portfolio companies in Rest Of Europe's veterinary sector.
Market Entry Consultants : Consultants advising companies on European expansion need region-specific data to develop market entry strategies and competitive positioning for Rest Of Europe markets.

Key Companies in the Rest Of Europe Veterinary PoC Diagnostics Market

Company	HQ	Ownership	Strongest segments
GENERAL ELECTRIC	United States	Public Company	Commercial Engines & Services,Defense & Propulsion Technologies,Additive and Advanced Components,
IDEXX LABORATORIES, INC.	United States	Public Company	Companion Animal Group (in-clinic analyzers, reference labs, software, services),Livestock, Poultry and Dairy Diagnostics,Water Quality Products,
THERMO FISHER SCIENTIFIC INC.	United States	Public Company	Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
BIONOTE	South Korea	Public Company	Veterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
BIOM�RIEUX	France	Public Company	Microbiology ID/AST systems (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Sepsis, immunoassay, and specialty markers (VIDAS, Hybiome CLIA),
VIRBAC	France	Public Company	Companion animal parasiticides (e.g., Prevexto),Companion animal chronic-care nutrition (e.g., Vikaly, petfood),Behavior and stress management (Zenidog/Zenifel),

GENERAL ELECTRIC

General Electric is a publicly traded United States company founded in 1892 that operates with 57,000 employees.

IDEXX LABORATORIES, INC.

IDEXX Laboratories, Inc. is a publicly traded United States company founded in 1983 with 11,000 employees.

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees.

BIONOTE

BioNote is a publicly traded South Korean company founded in 2003 with 298 employees.

BIOM�RIEUX

bioM�rieux is a publicly traded French company founded in 1963 with 14,894 employees.

VIRBAC

Virbac is a publicly traded French company founded in 1968 with 6,442 employees.

Reasons to Buy this Report

Regional Market Segmentation : Gain detailed insights specific to Rest Of Europe's veterinary PoC diagnostics market, distinct from Western European trends, enabling targeted regional strategy development.
Growth Opportunity Identification : Identify high-potential sub-markets and emerging opportunities within Rest Of Europe where veterinary diagnostic adoption is accelerating fastest.
Competitive Landscape Analysis : Understand regional competitive dynamics, local player strategies, and market entry barriers specific to Rest Of Europe's veterinary diagnostics sector.
Investment Decision Support : Make informed investment and expansion decisions with accurate market sizing, CAGR projections, and regional growth drivers through 2031.
Strategic Market Positioning : Develop region-specific go-to-market strategies leveraging insights on pet ownership trends, healthcare awareness, and veterinary practice modernization in Rest Of Europe.

Frequently asked questions

What is the market size of veterinary PoC diagnostics in Rest Of Europe?

Rest Of Europe's veterinary PoC diagnostics market was valued at USD 34.6 million in 2026 and is forecast to reach USD 46.6 million by 2031.

What is the growth rate for veterinary PoC diagnostics in Rest Of Europe?

Rest Of Europe's veterinary PoC diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2031.

What factors are driving growth in Rest Of Europe's veterinary PoC diagnostics market?

Rest Of Europe's market growth is driven by increasing pet ownership, rising animal health awareness, improving veterinary infrastructure, and growing demand for rapid diagnostic solutions in clinical settings.

How does Rest Of Europe's veterinary PoC diagnostics market compare to other European regions?

Rest Of Europe represents a secondary but growing market segment within Europe, with a 6.1% CAGR reflecting steady expansion supported by technology transfer from Western European markets and increasing veterinary investment.

What types of PoC diagnostic devices are most relevant in Rest Of Europe?

Rest Of Europe shows strong demand for portable, cost-effective diagnostic devices including rapid blood tests, immunoassays, and point-of-care analyzers that enable quick clinical decision-making in veterinary practices.

RESEARCH METHODOLOGY

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; and white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary PoC diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary PoC diagnostics market. Primary sources from the demand side include small and large animal veterinarians, veterinary clinic and hospital owners, managers of livestock farms and dairy operations, directors of veterinary diagnostic laboratories, officials from government animal health and regulatory agencies, and procurement and purchasing teams from veterinary clinics, hospitals, and farm operations.

A breakdown of the primary respondents is provided below:

Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region

Veterinary PoC Diagnostics Market
Size, and Share

Note: C-level executives include CEOs, COOs, CTOs, and VPs.

Other designations include sales, marketing, and product managers.

Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary PoC diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Veterinary PoC Diagnostics Market : Top-Down and Bottom-Up Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

The veterinary PoC diagnostics market comprises products and technologies used for rapid, on-site diagnosis of diseases and health conditions in animals, enabling immediate clinical decision-making without reliance on centralized laboratories. The market includes consumables (such as test kits, cartridges, strips, and reagents) and instruments (including portable analyzers and handheld diagnostic devices) and covers key technologies such as molecular diagnostics (PCR-based, isothermal amplification, and CRISPR-based methods), immunodiagnostics, and other techniques, including clinical chemistry and hematology. It serves both companion animals (dogs, cats, horses, and others) and livestock (cattle, pigs, poultry, and others), with applications spanning infectious disease detection, routine health monitoring, and preventive care across veterinary clinics, farms, and field settings.

Key Stakeholders

Veterinary PoC diagnostic kit manufacturers
Molecular diagnostic technology providers & PoC instrument manufacturers
Reagent & consumable suppliers
Veterinary clinics & hospitals
Livestock farms, dairy farms & integrated animal production companies
Government animal health authorities & surveillance agencies
Veterinary diagnostic laboratories
Veterinarians & field-based animal health service providers
Academic & veterinary research institutions
Contract manufacturers & OEM partners
Distributors & regional channel partners
Market research & consulting firms
Investors & venture capital firms

Report Objectives

To define, describe, segment, and forecast the veterinary PoC diagnostics market by product, technology, animal type, and region, in terms of value
To define, describe, segment, and forecast the veterinary PoC diagnostics market by product and region, in terms of volume
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary PoC diagnostics market
To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies2
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the veterinary PoC diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the veterinary PoC diagnostics market and comprehensively analyze their core competencies and market shares
To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

1. Micromarkets are defined as the further segments and subsegments of the veterinary PoC diagnostics market included in the report.

2. Core competencies of companies are captured in terms of the key developments and strategies adopted by them to sustain their market positions.

Available customizations:

With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of Rest of Europe veterinary PoC diagnostics market into Austria, Finland, Switzerland, and other countries
Further breakdown of Rest of Latin America veterinary PoC diagnostics market into Colombia, Chile, and other countries

Competitive Landscape Assessment

Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary PoC diagnostics market

Competitive leadership mapping for established players in the US

Get the Full Veterinary PoC Diagnostics Market Report

Full forecast, segment splits, and company analysis for all Veterinary PoC Diagnostics Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)